MercadoLibre Stock Is Down 9% in 2026 but Wall Street Still Sees 36% Upside

MercadoLibre has missed EPS estimates for three straight quarters, including Q4 2025 EPS of $11.03 versus $11.85 expected, even as revenue rose 44.6% to $8.76 billion. The stock is down 9.1% year to date and trades at $1,831.93, below the $2,490.27 consensus target but above the more conservative $2,097.44 base target. Analysts remain broadly constructive, but margin pressure from heavy investment, $337 million in FX losses, and a likely longer timeline for a $3,000 share price cap the near-term upside.

Analysis

MELI’s problem is not demand, it’s sequencing: management is still choosing to spend ahead of earnings power, and the market is punishing the mismatch because the near-term earnings base is the only thing supporting the multiple. The second-order effect is that every incremental dollar of logistics, credit, and first-party investment now competes with capital return and valuation support, so the stock behaves more like a long-duration growth asset than a “compounder” until margin inflection is visible. That creates a classic trap: strong top-line and cash flow growth can coexist with multiple compression if guidance implies another 2-3 quarters of sacrifice.

The more interesting read-through is competitive, not company-specific. Lower shipping thresholds and expanding first-party operations should pressure smaller regional e-commerce players and independent merchants first, because MELI can subsidize consumer conversion longer than they can. In fintech, the expanding credit portfolio is a double-edged sword: it boosts engagement and take-rate, but it also introduces latent credit-cycle risk that won’t show up in the P&L until funding costs or delinquency trends move against them. If Brazil growth slows, the balance-sheet leverage to consumer spend could turn from a moat into an earnings drag.

The market seems to be pricing in a 2026 inflection that may be too early. If capex remains elevated into next year, the stock can stay range-bound even if revenue compounding remains above peers, because the market will anchor to EPS revisions rather than GMV narratives. The real catalyst is not one more strong quarter of sales; it’s evidence that incremental investment is translating into operating leverage and lower fulfillment intensity per order. Absent that, the stock likely oscillates between “too expensive for value” and “too cheap for growth” without reclaiming its prior peak quickly.

The contrarian angle is that the move may be partly overdone if investors are extrapolating temporary FX and tax normalization into a structural margin reset. A lot of the bear case is timing risk masquerading as thesis risk: if FX stops detracting and operating leverage resumes, earnings can snap back faster than sentiment expects. But until management explicitly signals a capex plateau and stable margin trajectory, the burden of proof stays with the bulls.

Key Decisions for Investors

• Avoid chasing MELI outright here; wait for either a post-earnings drawdown toward the 200-day / prior support zone or a clear guide-to-margin inflection before adding risk. Near-term upside is capped unless the company proves the investment cycle is peaking.
• For investors already long MELI, sell covered calls 1-2 quarters out against core holdings to monetize implied volatility while the market is stuck in an earnings-revision reset. This improves carry while preserving participation if the turnaround comes later in 2026.
• Pair trade: long MS / short MELI over the next 1-3 months if the goal is cleaner earnings visibility and less valuation risk. MS is effectively neutral in this setup, so the relative-value leg isolates the market’s willingness to pay for earnings quality versus growth optionality.
• Use MELI downside protection via put spreads into the next print if consensus remains optimistic on margins; a 10%-15% downside move is plausible if management signals another heavy investment year. The trade is attractive because the current setup is driven by credibility risk, not demand collapse.
• Contrarian long setup: accumulate MELI only if management shows two consecutive quarters of margin stabilization plus better conversion of OCF into net income. That is the point where the market can re-rate the stock back toward consensus targets with 12-month upside re-anchoring.